Ultragenyx Pharmaceutical Aktie - RARE

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Current Price

42,07

Gebot

37,07

Fragen

57,00

Volumen

819.820

41,58 Tagesbereich 43,57

37,02 52-Wochen-Bereich 60,37

Marktkapitalisierung

3,885B

Handelsende

43,65

Handelsbeginn

43,295

Letzte Trade

Letzter Handelszeitpunkt

Finanzvolumen

US$ 34.504.351

VWAP

42,0877

Durchschnittliches Volumen (3 Mio.)

826.160

Ausgegebene Aktien

92.344.268

Dividendenrendite

Kurs-Gewinn-Verhältnis

-6,40

Gewinn pro Aktie (EPS)

-6,57

Erlöse

434,25M

Nettogewinn

-606,64M

Ultragenyx Pharmaceutical Inc is a US-based biopharmaceutical company. It identifies, acquires, develops, and commercialize novel products for the treatment of serious rare and ultra-rare diseases, with the focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Cr... Ultragenyx Pharmaceutical Inc is a US-based biopharmaceutical company. It identifies, acquires, develops, and commercialize novel products for the treatment of serious rare and ultra-rare diseases, with the focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mehr anzeigen

Sektor

Pharmaceutical Preparations

Branche

Pharmaceutical Preparations

Website

www.ultragenyx.com

Hauptsitz

Wilmington, Delaware, USA

Gegründet

Ultragenyx Pharmaceutical Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RARE. The last closing price for Ultragenyx Pharmaceutical was US$43,65. Over the last year, Ultragenyx Pharmaceutical shares have traded in a share price range of US$ 37,02 to US$ 60,37.

Ultragenyx Pharmaceutical currently has 92.344.268 shares in issue. The market capitalisation of Ultragenyx Pharmaceutical is US$4,03 billion. Ultragenyx Pharmaceutical has a price to earnings ratio (PE ratio) of -6.40.

Gesamtfluss

Bullisch

Nettoprämie

548k

Calls / Puts

100,00%

Käuf. / Verkä.

100,00%

OTM / ITM

100,00%

Sweeps

0,00%

Ultragenyx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

NOVATO, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies...

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NOVATO, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies...

Form 8-K - Current report

Ultragenyx Announces First Patient Dosed in Pivotal Phase 3 Aspire Study Evaluating GTX-102 in Angelman Syndrome

NOVATO, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), today announced that the first patient has been dosed in the pivotal Phase 3 Aspire study...

Form 8-K - Current report

Ultragenyx Submits Biologics License Application to the U.S. FDA for UX111 AAV Gene Therapy for the Treatment of Sanfilippo Syndrome Type A (MPS IIIA)

NOVATO, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0.92	2.23572296476	41.15	46.24	41.06	1290214	42.84499948	CS
4	-4.6	-9.8564388258	46.67	47.12	40.05	1014279	43.28140048	CS
12	-14.74	-25.9461362436	56.81	57.09	40.05	826160	47.21763315	CS
26	-0.29	-0.684608120869	42.36	60.37	40.05	754805	49.76940956	CS
52	-6.38	-13.1682146543	48.45	60.37	37.02	779830	46.94744453	CS
156	-30.15	-41.7474383827	72.22	85.53	31.52	707665	46.49741864	CS
260	-6.84	-13.9848701697	48.91	179.647	31.52	617541	60.3988225	CS

RARE - Frequently Asked Questions (FAQ)

What is the current Ultragenyx Pharmaceutical share price?

The current share price of Ultragenyx Pharmaceutical is US$ 42,07

How many Ultragenyx Pharmaceutical shares are in issue?

Ultragenyx Pharmaceutical has 92.344.268 shares in issue

What is the market cap of Ultragenyx Pharmaceutical?

The market capitalisation of Ultragenyx Pharmaceutical is USD 4,03B

What is the 1 year trading range for Ultragenyx Pharmaceutical share price?

Ultragenyx Pharmaceutical has traded in the range of US$ 37,02 to US$ 60,37 during the past year

What is the PE ratio of Ultragenyx Pharmaceutical?

The price to earnings ratio of Ultragenyx Pharmaceutical is -6,4

What is the cash to sales ratio of Ultragenyx Pharmaceutical?

The cash to sales ratio of Ultragenyx Pharmaceutical is 8,95

What is the reporting currency for Ultragenyx Pharmaceutical?

Ultragenyx Pharmaceutical reports financial results in USD

What is the latest annual turnover for Ultragenyx Pharmaceutical?

The latest annual turnover of Ultragenyx Pharmaceutical is USD 434,25M

What is the latest annual profit for Ultragenyx Pharmaceutical?

The latest annual profit of Ultragenyx Pharmaceutical is USD -606,64M

What is the registered address of Ultragenyx Pharmaceutical?

The registered address for Ultragenyx Pharmaceutical is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801

What is the Ultragenyx Pharmaceutical website address?

The website address for Ultragenyx Pharmaceutical is www.ultragenyx.com

Which industry sector does Ultragenyx Pharmaceutical operate in?

Ultragenyx Pharmaceutical operates in the PHARMACEUTICAL PREPARATIONS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
VRMEVerifyMe Inc	US$ 2,57 (52,98%)	57,83M
WKEYWISeKey International Holdings AG	US$ 10,041 (52,83%)	6,72M
DATSDatChat Inc	US$ 4,8105 (49,86%)	158,65M
CDTConduit Pharmaceuticals Inc	US$ 0,1214 (48,05%)	1,17B
INTZIntrusion Inc	US$ 2,8888 (44,44%)	40,61M
IGMSIGM Biosciences Inc	US$ 2,095 (-66,21%)	5,81M
CDTGCDT Environmental Technology Investment Holdings Ltd	US$ 1,87 (-51,30%)	2,28M
MODVModivCare Inc	US$ 6,51 (-47,88%)	2,73M
AIFUAIX Inc	US$ 0,420501 (-47,76%)	7,85M
MRSNMersana Therapeutics Inc	US$ 0,691 (-46,85%)	58,44M
CDTConduit Pharmaceuticals Inc	US$ 0,1214 (48,05%)	1,16B
NVDANVIDIA Corporation	US$ 135,91 (-3,00%)	203,27M
RGTIRigetti Computing Inc	US$ 8,9299 (-11,06%)	175,21M
VMARVision Marine Technologies Inc	US$ 2,14 (40,79%)	174,99M
DATSDatChat Inc	US$ 4,8105 (49,86%)	158,56M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Ultragenyx Pharmaceutical Inc (RARE) Börsenkurse

Ultragenyx Pharmaceutical Inc (RARE)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über Ultragenyx Pharmaceutical Inc

Option-Flow Ultragenyx Pharmaceutical (RARE)

Gesamtfluss

Bullisch

Nettoprämie

548k

Calls / Puts

100,00%

Käuf. / Verkä.

100,00%

OTM / ITM

100,00%

Sweeps

0,00%

RARE Neueste Nachrichten

RARE - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen